Private-equity firm Permira has hired banks to lead an initial public offering of Arysta LifeScience that is expected to value the agricultural chemical maker at about $4 billion including debt, according to people familiar with the matter.
from WSJ.com: US Business http://ift.tt/1oCPdel
via IFTTT
from WSJ.com: US Business http://ift.tt/1oCPdel
via IFTTT
No comments:
Post a Comment